Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 11/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16803034 | 0.96 | CYP2C9 (0.43) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL11210312 | 0.90 | CYP2C9 (0.52) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL10862270 | 0.90 | CYP2C9 (0.52) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL4803860 | 0.89 | CYP2C9 (0.50) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL4803851 | 0.89 | CYP2C9 (0.50) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL21321908 | 0.89 | MAPT (0.44) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL11190177 | 0.88 | SPHK1 (0.50) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL11191518 | 0.88 | SPHK1 (0.50) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL11190738 | 0.88 | SPHK1 (0.50) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL11191866 | 0.88 | CYP2C9 (0.49) | CYP2C9MAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2883938-B1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DAINIPPON INK & CHEMICALS (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-9650572-B2 | Liquid crystal composition, liquid crystal display device, and liquid crystal display | DIC CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-20160060524-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY | DIC CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-2883938-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT, AND LIQUID CRYSTAL DISPLAY | DIC Corporation (JP) | 2015-06-17 | — | — | EP | disclosed |
| US-8110256-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2012-02-07 | — | — | US | disclosed |
| US-7842357-B2 | Tetrahydropyran compound, liquid crystal, composition and liquid crystal display device containing the liquid crystal composition | CHISSO CORPORATION (JP) | 2010-11-30 | — | — | US | disclosed |
| US-7838087-B2 | Benzene derivative, liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-7790915-B2 | Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and LCD device including the liquid crystal composition | CHISSO PETROCHEMICAL CORPORATION (JP) | 2010-09-07 | — | — | US | disclosed |
| US-7749403-B2 | Monofluorinated terphenyl compound having alkenyl, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20090321683-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| US-7524540-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7435455-B2 | Dihydrocoumarin derivative, liquid crystal composition containing the same, and liquid crystal display device | CHISSO CORPORATION (JP) | 2008-10-14 | — | — | US | disclosed |
| US-7404992-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2008-07-29 | — | — | US | disclosed |
| US-7390539-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2008-06-24 | — | — | US | disclosed |
| US-20070200092-A1 | Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device | JNC PETROCHEMICAL CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-7247355-B2 | Liquid crystal compound having chroman ring, liquid crystal composition comprising the compound and liquid crystal display device comprising the composition | CHISSO CORPORATION (JP) | 2007-07-24 | — | — | US | disclosed |
| US-20070108411-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2007-05-17 | — | — | US | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070012898-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2007-01-18 | — | — | US | disclosed |
| EP-1743930-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2007-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | LEF1, CFD, FOXO1 | CYP2C9 3113/4885MAPT 3479/4885MEN1 1518/4885 |
| US-20070200092-A1 | Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device | CCND2, YBX1, CNKSR1 | CYP2C9 3032/4885MAPT 1989/4885MEN1 3396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.